Wyss-Quintana FS

Idioma: Inglés [English version]
Referencias bibliográficas: 20
Paginas: 4-7
Archivo PDF: 115.81 Kb.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Alfonso F, Almonte K, Arai K, Bacal F, Drago Silva JM, Galeano Figueredo J et al. Ibero-American cardiovascular journals. Proposals for a much-needed cooperation. Rev Esp Cardiol. 2009; 62 (9): 1060-1067.

2. Task Force of the Latin American Society of Hypertension. Guidelines on the management of arterial hypertension and related comorbidities in Latin America. J Hypertens. 2017; 35 (8): 1529-1545. doi: 10.1097/HJH.0000000000001418.

3. Wyss F, Coca A, Lopez-Jaramillo P, Ponte-Negretti C et al. Position statement of the Interamerican Society of Cardiology (IASC) on the current guidelines for the prevention, diagnosis and treatment of arterial hypertension 2017-2020. Int J Cardiol Hypertens. 2020; 6: 100041. doi: 10.1016/j.ijchy.2020.100041.

4. Ponte-Negretti CI, Wyss FS, Piskorz D, Liprandi AS, Lorenzatti A, Machado L et al. Considerations and guidance for the structure, organisation, and operation of cardiometabolic prevention units: a consensus statement of the Inter-American Society of Cardiology. Glob Heart. 2021; 16 (1): 27. doi: 10.5334/gh.960.

5. Barbosa ECD, Ramirez A, Beaney T, Kobeissi E, Lopez-Jaramillo P, Hernánez-Hernández R et al. May measurement month 2017: Latin America. J Hypertens. 2020; 38 (6): 1183-1188. doi: 10.1097/HJH.0000000000002370.

6. Camafort M, Alcocer L, Coca A, Lopez-Lopez JP, López-Jaramillo P, Ponte-Negretti CI et al. Registro Latinoamericano de monitorización ambulatoria de la presión arterial (MAPA-LATAM): una necesidad urgente, Revista Clínica Española. 2021; 221 (9): 547-552.

7. Ponte-Negretti CI, Isea-Pérez J, Lanas F, Medina J, Gómez-Mancebo J, Morales E et al. Dislipidemia aterogénica en Latinoamérica: prevalencia, causas y tratamiento. Un consenso. Rev Mex Cardiol. 2017; 28 (2): 54-85.

8. Ponte-Negretti CI, Isea-Perez JE, Lorenzatti AJ, Lopez-Jaramillo P, Wyss-Q FS, Pintó X et al. Atherogenic Dyslipidemia in Latin America: Prevalence, causes and treatment: Expert's position paper made by The Latin American Academy for the Study of Lipids (ALALIP) Endorsed by the Inter-American Society of Cardiology (IASC), the South American Society of Cardiology (SSC), the Pan-American College of Endothelium (PACE), and the International Atherosclerosis Society (IAS). Int J Cardiol. 2017; 243: 516-522. doi: 10.1016/j.ijcard.2017.05.059.

9. Ponte-Negretti CI, Wyss FS, Piskorz D, Santos RD, Villar R, Lorenzatti A et al. Latin American Consensus on management of residual cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic Risk (ALALIP) endorsed by the Inter-American Society of Cardiology (IASC), the International Atherosclerosis Society (IAS), and the Pan-American College of Endothelium (PACE). Arch Cardiol Mex. 2022; 92 (1): 99-112. doi: 10.24875/ACM.21000005.

10. Liprandi AS, Liprandi MIS, Zaidel EJ, Aisenberg GM, Baranchuk A, Barbosa ECD et al. Influenza vaccination for the prevention of cardiovascular disease in the Americas: consensus document of the Inter-American Society of Cardiology and the Word Heart Federation. Glob Heart. 2021; 16 (1): 55. doi: 10.5334/gh.1069.

11. Sosa-Liprandi A, Sosa Liprandi MI, Alexánderson E, Avezum A, Lanas F, López-Jaramillo JP et al. Clinical impact of the polypill for cardiovascular prevention in Latin America: a consensus statement of the Inter-American Society of Cardiology. Glob Heart. 2019; 14 (1): 3-16.e1. doi: 10.1016/j.gheart.2018.10.001.

12. Zaidel EJ, Wyss Quintana FS, Sosa Liprandi A, Mendoza I, Ma?rquez MF, Nun?ez E et al. Hidroxicloroquina. Mensajes desde la cardiología en tiempos de pandemia por coronavirus. Medicina (Buenos Aires). 2020; 80: 271-274.

13. Delgado D, Wyss Quintana F, Perez G, Sosa Liprandi A, Ponte-Negretti C, Mendoza I et al. Personal safety during the COVID-19 pandemic: realities and perspectives of Healthcare Workers in Latin America. Int J Environ Res Public Health. 2020; 17 (8): 2798. doi: 10.3390/ijerph17082798.

14. Lopez Santi R, Piskorz DL, Marquez MF, Ramirez Ramos C, Renna NF, Ibarrola M et al. Impact of the pandemic on noninfected cardiometabolic patients: a survey in countries of latin america-rationale and design of the CorCOVID LATAM Study. CJC Open. 2020; 2 (6): 671-677. doi: 10.1016/j.cjco.2020.08.007.

15. Sosa Liprandi A, Zaidel EJ, Lopez Santi R, Araujo JJ, Baños González MA, Busso JM et al. Influenza and pneumococcal vaccination in non-infected cardiometabolic patients from the Americas during the COVID-19 pandemic. A sub-analysis of the CorCOVID-LATAM Study. Vaccines (Basel). 2021; 9 (2): 123. doi: 10.3390/vaccines9020123.

16. Piskorz D, Puente Barragán A, López Santi R, Vázquez G, Solache Ortiz G, Ramírez Zambrano L et al. Psychological impact of the pandemic on ambulatory cardiometabolic patients without evidence of SARS-CoV-2 infection. The CorCOVID Latam Psy Study. Curr Probl Cardiol. 2021; 46 (4): 100737. doi: 10.1016/j.cpcardiol.2020.100737.

17. Santi RL, Márquez MF, Piskorz D, Saldarriaga C, Lorenzatti A, Wyss F et al. Ambulatory patients with cardiometabolic disease and without evidence of COVID-19 during the pandemic. The CorCOVID LATAM Study. Glob Heart. 2021; 16 (1): 15. doi: 10.5334/gh.932.

18. Saldarriaga-Giraldo CI, Ramirez-Ramos CF, Lopez-Santi R, Lanas F, Valdés Martín A, Sotomayor Perales JL et al. Gender-related differences in the impact of COVID-19 pandemic in cardiometabolic patients in Latin America: The CorCOVID LATAM Gender Sub-study. Curr Probl Cardiol. 2022; 47 (3): 101075. doi: 10.1016/j.cpcardiol.2021.101075.

19. Gómez-Mesa JE, Galindo-Coral S, Montes MC, Alarco W, Barisani JL, Magaña A et al. Latin-American Registry of Cardiovascular Disease and COVID-19: rationale and design of the CARDIO COVID 19-20 registry. Glob Heart. 2021; 16 (1): 14. doi: 10.5334/gh.925.

20. Iomini PA, Parodi JB, Farina JM, Saldarriaga C, Liblik K, Mendoza I et al. Neglected tropical diseases and their impact on cardiovascular health (The NET-Heart Project). Medicina (B Aires). 2021; 81 (5): 808-816.